UB scientists Ram Samudrala, PhD, and Zackary M. Falls, PhD, talk about the new platform to make drug discovery faster and less expensive while also being safe and effective.

Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are ...

Industry veteran Catherine Owen Adams expects external innovation will be key to getting the brain-focused drug developer to “the next level.” ...

Pfizer PFE has committed significant resources for the development of treatments in the fields of oncology, internal medicine ...

MUSC Health Lancaster welcomed its first-ever class of internal medicine residents, marking a historic step toward addressing ...

Eli Lilly's Zepbound is the first and only approved dual GLP-1/GIP agonist, and Lilly is also working on its own triple agonist. So, with this acquisition, Novo Nordisk is trying to catch up to its ...

Annual Alzheimer's clinical trials pipeline report shows increased reason for optimism by University of Nevada, Las Vegas edited by Sadie Harley, reviewed by Andrew Zinin Editors' notes ...

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime editing-based pipeline focus to liver disease and programs funded by external ...

Johnson & Johnson’s latest quarter was shaped by ongoing growth in its innovative medicine and MedTech segments, as highlighted on the company’s earnings call. CEO Joaquin Duato cited 4.2% operational ...

Pharma Sage discontinues Zulresso, drops pair of pipeline prospects as it creeps toward 2026 cash cliff By Eric Sagonowsky Oct 30, 2024 8:55am Sage Therapeutics Zulresso Zurzuvae Biogen ...